Advanced Wound

Management Starts Here

MD Biologix is proud to be the National Exclusive Distributor of XCelliStem®. XCelliStem® is our flagship wound powder, powered by proprietary MTP technology. Since earning FDA clearance in 2018, it has helped improve wound healing outcomes for thousands of patients across hospitals in the United States.

  • *Clinical use should be supported by documented medical necessity in accordance with applicable payer requirements.*

Clinical Results

Advanced Wound Management Powered by Multi-Tissue ECM

Despite advances in wound care technology, chronic wounds continue to limit healing success for many patients.

Clinical Results Our Multi-Tissue Platform (MTP™) was developed to address unmet clinical needs in the management of complex and hard-to-heal wounds.

What's in MTP™?

XCelliStem® Wound Powder is a naturally derived extracellular matrix containing a broad composition of structural and matrix proteins, characterized to include:

  • Collagen (TYPES I, III, IV, V)
  • Elastin
  • Hyaluronic Acid
  • Fibroblast Growth Factor (FGF)
  • Vascular Endothelial Growth Factor (VEGF)
  • Pidermal Growth Factor (EGF)
  • Laminin
  • Fibronectin
  • Exosomes

The above components represent the characterized composition of XCelliStem® Wound Powder as determined by device characterization testing. The presence of these components does not represent a claim of pharmacological activity. XCelliStem® is a medical device cleared for wound management under FDA 510(k) K172593.

XCelliStem® Wound Powder

Our proprietary MTP™ technology is a blend of naturally occurring extracellular matrix materials from multiple tissue types, designed to provide the body with a wider variety of the components present in the extracellular matrix, supporting an optimal microenvironment for wound management.

MD Biologix is proud to be the Exclusive National Distributor of XCelliStem®

Indications for Use

The XCelliStem Wound Powder is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, diabetic ulcers, venous ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second- degree burns, and skin tears), and draining wounds.

  • Donor sites/grafts
  • Podiatric
  • Partial and full-thickness wounds
  • Post-Moh's surgery
  • Wound dehiscence
  • Second degree burns
  • Post-laser surgery
  • Pressure, diabetic and venous ulcers
  • Surgical wounds
  • Tunneled/undermined wounds

Available Product Sizes

HCPCS FDA 510(k): Part Description
A2004
K172593
XSWP0250
XcelliStem Wound Powder 250mg
A2004
K172593
XSWP0500
XcelliStem Wound Powder 500mg
A2004
K172593
XSWP01000
XcelliStem Wound Powder 1000mg